Tecnología desarrollada por retinIA para beneficiar la salud visual

Desarrollamos y validamos nuestros propios modelos de inteligencia artificial en colaboración con profesionales de la salud visual.

Agosto, 2021. JMIR Formative Research

Screening diabetic retinopathy using an automated retinal image analysis system in Mexico: independent and assistive use cases

Enero, 2021. MedRxiv

State-of-the-Art Risk Models for Diabetes, Hypertension, Visual Diminution, and COVID-19 Severity in Mexico

Mayo, 2022.

Screening Multiple Retinal Diseases on Primary Care Population Using Portable Non-Mydriatic Cameras

Agosto, 2024. MedRxiv

Comparative Performance of retinIA, an AI-powered Ophthalmic Screening Tool, and First-Year Residents in Retinal Disease Detection and Glaucoma Assessment: A Study in a Mexican Tertiary Care Setting

Mayo, 2025. Front. Ophthalmol.

Synergistic AI-resident approach achieves superior diagnostic accuracy in tertiary ophthalmic care for glaucoma and retinal disease